Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 09, 2017 07:00 ET | Source: RedHill Biopharma Ltd.

RedHill Biopharma Announces Last Patient Enrolled in the Phase III Study with RHB-104 for Crohn’s Disease

Top-line results are expected to be announced in mid-2018 The Phase III study evaluating RHB-104 for Crohn’s disease (MAP US study) is a randomized, double-blind, placebo-controlled study that is...
November 08, 2017 16:40 ET | Source: Nature's Sunshine Products, Inc.

Nature’s Sunshine Products Reports Third Quarter 2017 Financial Results

Third quarter net sales of $89.3 million were up 4.5 percent year-over-year Net income of $2.4 million attributable to common shareholders, or $0.13 per diluted common share during the third...
November 08, 2017 16:05 ET | Source: LifeVantage Corporation

LifeVantage Announces Financial Results for the First Quarter of Fiscal 2018

Initiated commercial testing and training of new ecommerce business model developed for entry into China Launched two new products: Omega+ and Vitality Stack Launched beta test of new LifeVantage...
November 08, 2017 10:00 ET | Source: Juvenile Diabetes Research Foundation Canada

JDRF’s T1D Heroes Advocating for Insulin Pump Coverage in Manitoba

WINNIPEG, Manitoba, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Manitoba Lobby Day 2017 is an opportunity to make a difference. Today, 10 T1D Heroes – advocates living with type 1 diabetes (T1D) – are at the...
November 08, 2017 08:00 ET | Source: BioSig Technologies, Inc.

BioSig Technologies to Speak at Digital Silver Forum in Helsinki, Finland on November 28

Santa Monica, CA, Nov. 08, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
November 07, 2017 09:00 ET | Source: CURE Pharmaceutical; Therapix Biosciences Ltd.

Cure Pharmaceutical Enters Into Product Development Agreement with Therapix Biosciences To Develop Cannabinoid-Based Product For Sleep Disorders

OXNARD, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Cure Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology announced today that it has entered into a product...
November 07, 2017 06:00 ET | Source: Invivoscribe, Inc.

Invivoscribe® Releases LymphoTrack® TRB Assay on MiSeq® and LymphoTrack® Minimal Residual Disease (MRD) Software

SAN DIEGO, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Invivoscribe® Technologies Inc., a global company with decades of experience providing clonality and biomarker test solutions for the fields of oncology...
November 07, 2017 05:53 ET | Source: Allergy Standards Limited

Allergy Standards Limited (ASL) attends the Greenbuild International Conference and Expo in Boston

Dublin, Ireland, Nov. 07, 2017 (GLOBE NEWSWIRE) -- The Greenbuild Conference and Expo is a great opportunity to meet and network with top suppliers and manufacturers of the latest green building...
November 06, 2017 16:11 ET | Source: PetIQ, Inc.

PetIQ, Inc. Reports Third Quarter Fiscal 2017 Financial Results

EAGLE, Idaho, Nov. 06, 2017 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (NASDAQ:PETQ), a leading pet medication and wellness company, today reported financial results for its third...
November 06, 2017 09:00 ET | Source: The Leona M. and Harry B. Helmsley Charitable Trust

Helmsley Charitable Trust Awards $52 Million to Support the Global Platform for the Prevention of Autoimmune Diabetes

New York, NY, Nov. 06, 2017 (GLOBE NEWSWIRE) -- The Leona M. and Harry B. Helmsley Charitable Trust today announced five new grants that will support the European, multinational Global Platform for...